Evaluating the synergistic effect of Mucuna prurines extract and sesame oil against the Parkinson’s disease zebrafish model: in-vivo/in-silico approach

References

• Ahmad S, Khan MB, Hoda MN, Bhatia K, Haque R, Fazili IS, Jamal A, Khan JS, Katare DP. 2012. Neuroprotective effect of sesame seed oil in 6-hydroxydopamine induced neurotoxicity in mice model: cellular, biochemical and neurochemical evidence. Neurochem Res. 37(3):516–526.
   PubMed Web of Science ®Google Scholar
• Anilakumar KR, Pal A, Khanum F, Bawa AS. 2010. Nutritional, medicinal and industrial uses of sesame (Sesamumindicum L.) seeds-an overview. Agric Conspec Sci. 75(4):159–168.
   Google Scholar
• Arenas E, Denham M, Villaescusa JC. 2015. How to make a midbrain dopaminergic neuron. Development. 142(11):1918–1936.
   PubMed Web of Science ®Google Scholar
• Author. n.d. An improved process for the production of Mucunapruriens seeds extract. Patent grant number:430/DEL/2009.
   Google Scholar
• Ayala A, Muñoz MF, Argüelles S. 2014. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longevity. 2014:1–31.
   Web of Science ®Google Scholar
• Blank M, Guerim LD, Cordeiro RF, Vianna MR. 2009. A one-trial inhibitory avoidance task to zebrafish: rapid acquisition of an NMDA-dependent long-term memory. Neurobiol Learn Mem. 92(4):529–534.
   Web of Science ®Google Scholar
• Budowski P, O'Connor RT, Field ET. 1950. Sesame oil. IV. Determination of free and bound sesamol. J Am Oil Chem Soc. 27(8):307–310.
   Web of Science ®Google Scholar
• Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. 2009. A highly reproducible rotenone model of Parkinson's disease. Neurobiol Dis. 34(2):279–290.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang DQ, Liao Z, Wang B, Gong S, Wang C, Zhang MZ, Wang GH, Cai H, Liao FF, Xu JP. 2015. Anti-oxidant polydatin (piceid) protects against substantianigral motor degeneration in multiple rodent models of Parkinson’s disease. Mol Neurodegener. 10(1):1–14.
   Google Scholar
• Chong CM, Zhou ZY, Razmovski-Naumovski V, Cui GZ, Zhang LQ, Sa F, Hoi PM, Chan K, Lee SM. 2013. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Neurosci Lett. 543:121–125.
   PubMed Web of Science ®Google Scholar
• Claiborne AL. 1985. Catalase activity. CRC handbook of methods for oxygen radical research. CRC press, 1:283–284.
   Google Scholar
• Dogra N, Mani RJ, Katare DP. 2020. Protein interaction studies for Understanding the tremor pathway in Parkinson’s disease. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 19(10):780–790.
   Web of Science ®Google Scholar
• Dos Santos EU, Sampaio TF, Tenório dos Santos AD, Bezerra Leite FC, da Silva RC, Crovella S, Asano AG, Asano NM, de Souza PR. 2019. The influence of SLC 6A3 and DRD 2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease. J Pharm Pharmacol. 71(2):206–212.
   PubMed Web of Science ®Google Scholar
• Duke JA. 2002. Handbook of medicinal herbs. CRC press.
   Google Scholar
• Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH, Mohnot S. 2009. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res. 205(1):38–44.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres Jr V, Featherstone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7(2):88–95.
   PubMed Web of Science ®Google Scholar
• Fazli IS, Abdin MZ, Jamal A, Ahmad S. 2005. Interactive effect of sulphur and nitrogen on lipid accumulation, acetyl-CoA concentration and acetyl-CoA carboxylase activity in developing seeds of oilseed crops (brassica campestris L. and eruca sativa mill. Plant Sci. 168(1):29–36.
   Web of Science ®Google Scholar
• Garrabou G, Gonzalez-Casacuberta I, Juarez-Flores D, Moren C. 2019. Bioenergetics and autophagic imbalance in patients-derived cell models of Parkinson disease supports systemic dysfunction in neurodegeneration. Front Neurosci. 13:894.
   Web of Science ®Google Scholar
• Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. 2014. Swisstargetprediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 42(W1):W32–W38.
   PubMed Web of Science ®Google Scholar
• González-Casacuberta I, Juárez-Flores DL, Morén C, Garrabou G. n.d. Bioenergetics and autophagic imbalance Parkinson ‘s disease Foundation. [accessed 2019 Sept 19]. https://www.parkinson.org/Understanding-Parkinsons/Statistics.
   Google Scholar
• Habig WH, Pabst MJ, Fleischner G, Gatmaitan Z, Arias IM, Jakoby WB. 1974. The identity of glutathione S-transferase B with ligandin, a major binding protein of liver. Proc Natl Acad Sci USA. 71(10):3879–3882.
   PubMed Web of Science ®Google Scholar
• Horai Y, Kakimoto T, Takemoto K, Tanaka M. 2017. Quantitative analysis of histopathological findings using image processing software. J Toxicol Pathol. 30(4):351–358.
   Web of Science ®Google Scholar
• Hussian G, Manyam BV. 1997. Mucuna pruriens proves more effective than L-DOPA in Parkinson's disease animal model. Phytotherapy Research: An International Journal Devoted to Medical and Scientific Research on Plants and Plant Products. 11(6):419–423.
   Google Scholar
• Johnson SL, Park HY, DaSilva NA, Vattem DA, Ma H, Seeram NP. 2018. Levodopa-reduced Mucunapruriens seed extract shows neuroprotective effects against Parkinson’s disease in murine microglia and human neuroblastoma cells, Caenorhabditiselegans, and Drosophila melanogaster. Nutrients. 10(9):1139.
   Google Scholar
• Jollow DJ, Mitchell JR, Zampaglione NA, Gillette JR. 1974. Bromobenzene-induced liver necrosis. protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 11(3):151–169.
   PubMed Web of Science ®Google Scholar
• Kasture S, Pontis S, Pinna A, Schintu N, Spina L, Longoni R, Simola N, Ballero M, Morelli M. 2009. Assessment of symptomatic and neuroprotective efficacy of Mucuna pruriens seed extract in rodent model of Parkinson’s disease. Neurotox Res. 15(2):111–122.
   Web of Science ®Google Scholar
• Khatri DK, Juvekar AR. 2016. Abrogation of locomotor impairment in a rotenone-induced Drosophila melanogaster and zebrafish model of Parkinson's disease by ellagic acid and curcumin. Int J Nutr, Pharmacol, Neurol Dis. 6(2):90.
   Google Scholar
• Khotimah H, Ali M, Sumitro SB, Widodo MA. 2015. Decreasing α-synuclein aggregation by methanolic extract of Centella asiatica in zebrafish Parkinson's model. Asian Pac J Trop Biomed. 5(11):948–954.
   Google Scholar
• Lee KH, Cha M, Lee BH. 2020. Neuroprotective effect of antioxidants in the brain. Int J Mol Sci. 21(19):7152.
   PubMed Web of Science ®Google Scholar
• Magistrelli L, Ferrari M, Furgiuele A, Milner AV, Contaldi E, Comi C, Cosentino M, Marino F. 2021. Polymorphisms of dopamine receptor genes and Parkinson’s disease: clinical relevance and future perspectives. Int J Mol Sci. 22(7):3781.
   Web of Science ®Google Scholar
• Masato A, Plotegher N, Boassa D, Bubacco L. 2019. Impaired dopamine metabolism in Parkinson’s disease pathogenesis. Mol Neurodegener. 14(1):1–21.
   PubMed Web of Science ®Google Scholar
• Mirghani ME, Man YC, Jinap S, Baharin BS, Bakar J. 2003. Application of FTIR spectroscopy in determining sesamol in sesame seed oil. J Am Oil Chem Soc. 80(1):1–4.
   Web of Science ®Google Scholar
• Mishra S, Katare DP. 2017. Synergistic combination for chemoprevention of hepatocellular carcinoma: an in silico and in vitro approach. Basic Clin Pharmacol Toxicol. 120(6):532–540.
   Web of Science ®Google Scholar
• Naz F, Siddique YH. 2020. Role of genes and treatments for Parkinson’s disease. Open Biol J. 8(1).
   Google Scholar
• Orr ME, Sullivan AC, Frost B. 2017. A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol Sci. 38(7):637–648.
   Web of Science ®Google Scholar
• Park SH, Ryu SN, Bu Y, Kim H, Simon JE, Kim KS. 2010. Antioxidant components as potential neuroprotective agents in sesame (Sesamum indicum L.). Food Rev Int. 26(2):103–121.
   Google Scholar
• Perez-Lloret S, Barrantes FJ. 2016. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson's Disease. 2:16001.
   PubMed Web of Science ®Google Scholar
• Rai SN, Birla H, Singh SS, Zahra W, Patil RR, Jadhav JP, Gedda MR, Singh SP. 2015. Mucunapruriens protects against MPTP intoxicated neuroinflammation in Parkinson’s disease through NF-κB/pAKT signaling pathways. Front Aging Neurosci. 19(9):421.
   Google Scholar
• Rai SN, Birla H, Singh SS, Zahra W, Patil RR, Jadhav JP, Gedda MR, Singh SP. 2017a. Mucuna pruriens protects against MPTP intoxicated neuroinflammation in Parkinson’s disease through NF-κB/pAKT signaling pathways. Front Aging Neurosci. 9:421.
   PubMed Web of Science ®Google Scholar
• Rai SN, Birla H, Zahra W, Singh S.S, Singh S.P. 2017. Immunomodulation of Parkinson’s disease using Mucuna pruriens (Mp). J Chem Neuroanat. 85:27–35.
   PubMed Web of Science ®Google Scholar
• Rieck M, Schumacher-Schuh AF, Callegari-Jacques SM, Altmann V, Schneider Medeiros M, Rieder CR, Hutz MH. 2015. Is there a role for ADORA2A polymorphisms in levodopa-induced dyskinesia in Parkinson's disease patients? Pharmacogenomics. 16(6):573–582.
   PubMed Web of Science ®Google Scholar
• Saito R, Smoot ME, Ono K, Ruscheinski J, Wang PL, Lotia S, Pico AR, Bader GD, Ideker T. 2012. A travel guide to Cytoscape plugins. Nat Methods. 9(11):1069.
   PubMed Web of Science ®Google Scholar
• Shasmitha R. 2015. Health benefits of SesamumIndicum: A short review. Asian J Pharm Clin Res. 8(6):1–3.
   Google Scholar
• Siddiqui MA, Ahmad J, Farshori NN, Saquib Q, Jahan S, Kashyap MP, Ahamed M, Musarrat J, Al-Khedhairy AA. 2013. Rotenone-induced oxidative stress and apoptosis in human liver HepG2 cells. Mol Cell Biochem. 384(1):59–69.
   Web of Science ®Google Scholar
• Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Dilnashin H, Singh R, Singh SP. 2020. Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian mouse model. Oxid Med Cell Longevity. 2020:1–14.
   Web of Science ®Google Scholar
• Stockwell J, Jakova E, Cayabyab FS. 2017. Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration. Molecules. 22(4):676.
   Web of Science ®Google Scholar
• Vaz RL, Outeiro TF, Ferreira JJ. 2018. Zebrafish as an animal model for drug discovery in Parkinson’s disease and other movement disorders: a systematic review. Front Neurol. 9(347).
   Google Scholar
• Verma R, Nehru B. 2009. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Neurochem Int. 55(6):369–375.
   PubMed Web of Science ®Google Scholar
• Von Wrangel C, Schwabe K, John N, Krauss JK, Alam M. 2015. The rotenone-induced rat model of Parkinson's disease: behavioral and electrophysiological findings. Behav Brain Res. 279:52–61.
   PubMed Web of Science ®Google Scholar
• Wei Z, Li X, Li X, Liu Q, Cheng Y. 2018. Oxidative stress in Parkinson's disease: a systematic review and meta-analysis. Front Mol Neurosci. 5(11):236.
   Web of Science ®Google Scholar
• Weisman MI, Caiolfa VR, Parola AH. 1988. Adenosine deaminase-complexing protein from bovine kidney. isolation of two distinct subunits. J Biol Chem. 263(11):5266–5270.
   PubMed Web of Science ®Google Scholar
• Wright JR, Colby HD, Miles PR. 1981. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys. 206(2):296–304.
   PubMed Web of Science ®Google Scholar
• Yadav SK, Rai SN, Singh SP. 2016. Mucunapruriens shows neuroprotective effect by inhibiting apoptotic pathways of dopaminergic neurons in the paraquat mouse model of parkinsonism. Eur. J. Pharmaceut. Med. Res. 3:441–451.
   Google Scholar
• Yadav SK, Rai SN, Singh SP. 2017. Mucunapruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model. J Chem Neuroanat. 80:1–10.
   Web of Science ®Google Scholar
• Zhang X, Du L, Zhang W, Yang Y, Zhou Q, Du G. 2017. Therapeutic effects of baicalein on rotenone-induced Parkinson’s disease through protecting mitochondrial function and biogenesis. Sci Rep. 7(1):1–4.
   PubMed Web of Science ®Google Scholar